38241 Transplt autol hct/donor
Surgery
Also known as: Autologous HCT, ASCT
Transplantation of autologous hematopoietic cells reinfused to the patient after high-dose chemotherapy or radiation.
Clinical Context
Therapeutic reinfusion of previously harvested autologous cells for multiple myeloma, lymphoma, and other hematologic malignancies.
RVU Breakdown
| Work RVU | 2.93 |
| Practice Expense RVU | 1.33 |
| Malpractice RVU | 0.20 |
| Total RVU | 4.46 |
Est. Medicare Payment
$148.96
National estimate based on 2026 CMS PFS Conversion Factor ($33.40). Actual payment varies by locality (GPCI adjustment).
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.